TrialJAMA dermatology2024

Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical Trial.

Daying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.